Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ZGN-201
ZGN-201
Zafgen Presents Data on a New Class of Medicines to Treat Obesity at the American Diabetes Association Annual Meeting
BusinessWire
Sat, 06/26/10 - 11:17 am
Zafgen
ZGN-201
obesity